Regulation and biological activities of the autotaxin–LPA axis
Top Cited Papers
- 1 March 2007
- journal article
- review article
- Published by Elsevier in Progress in Lipid Research
- Vol. 46 (2) , 145-160
- https://doi.org/10.1016/j.plipres.2007.02.001
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Inhibition of transcellular tumor cell migration and metastasis by novel carba-derivatives of cyclic phosphatidic acidBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissuesJournal of Cellular Physiology, 2006
- Carba Analogs of Cyclic Phosphatidic Acid Are Selective Inhibitors of Autotaxin and Cancer Cell Invasion and MetastasisJournal of Biological Chemistry, 2006
- Autotaxin, a Secreted Lysophospholipase D, Is Essential for Blood Vessel Formation during DevelopmentMolecular and Cellular Biology, 2006
- The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastasesProceedings of the National Academy of Sciences, 2006
- Fluorogenic Phospholipid Substrate to Detect Lysophospholipase D/Autotaxin ActivityOrganic Letters, 2006
- Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrateBiochemical and Biophysical Research Communications, 2005
- The ins and outs of lysophosphatidic acid signalingBioEssays, 2004
- The emerging role of lysophosphatidic acid in cancerNature Reviews Cancer, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003